In part three of our podcast series, we discuss the Biden Administration’s commitment to “equity” in healthcare.

In part two of this podcast series, we discuss President Biden’s COVID-19 plan, campaign promises around healthcare and what’s to come for prescription drug pricing

In part one of this podcast series, we discuss the role of the cabinet secretary and how the White House and cabinet agencies shape healthcare policy.

In the first episode of A&M Disputes and Investigations Asia's 'The Lighthouse' podcast, Senior Directors Henry Chambers, Jacko Lo and Irene Siu discuss how activist short seller reports can impact companies, recent examples of these campaigns, and how a response can be provided in the event that a company is subject to such a report.

In this podcast, you will learn how Walmart is advancing healthcare initiatives and furthering the company’s goal of improving healthcare in the U.S.

On the latest Walden Pond Podcast, Managing Director Vincent Walden is joined by A&M’s own Managing Director Ernest Brod and Business Intelligence expert for a discussion on technology innovation in third-party due diligence and asset tracing, including bank, web, contact and location intelligence.

As the largest vaccine rollout in modern history is underway across the country, many organizations are now considering the impact of a vaccine and its rollout on their workforce and business. Join our experts as they discuss what they are seeing in their organizations and across the country.

In the latest Walden Pond Podcast, Managing Director Vincent Walden is joined by Sam Eastwood, Partner at Mayer Brown, for a discussion on key enforcement trends in Europe, human rights and data analytics, and the need for business transparency.

In the latest Walden Pond podcast episode, A&M Managing Director Vincent Walden speaks with Andrew Levine, Partner at Debevoise & Plimpton, for a discussion around compliance program and analytics trends for 2021.

A&M’s Michael Niarchos moderatea a podcast with Lockton Company’s’ Ryan Czado on pharmacy benefits and emerging healthcare trends. They discuss how organizations are revising their strategies to improve outcomes and manage costs.

Alvarez & Marsal’s Healthcare Industry Group experts return to the conversation to weigh in on why healthcare records are breached more frequently than other industry sectors and how they can mitigate and manage these added cyber risks.

Alvarez & Marsal Managing Director, Michael Niarchos, hosts a conversation with John O’Brien, Former Senior Advisor to the Secretary of Health and Human Services, where they will discuss Health and Human Services Final Drug Pricing Rebate Rule.

In the latest Walden Pond podcast episode, A&M Managing Director Vincent Walden speaks with Aaron Nicodemus, a staff writer and reporter at Compliance Week compliance innovation predictions for 2021, the impact of the recent COSO report on enterprise risk management and compliance, and the importance of compliance function being viewed as a strategic partner with the business.

Responding to the Continued COVID-19 Cases and Recent Surge, Health Systems Face Challenges and Respond with Solutions to Continue to Serve their Patients and Communities.

In Part 1 of our two-part Series, A&M experts provide critical ideas for healthcare organizations to implement and think about as they continue to remain vigilant in their cybersecurity measures.